ADC Therapeutics (ADCT) Operating Expenses (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly Operating Expenses of $46.1 million for Q1 2026, down 10.49% year-on-year from $51.5 million in Q1 2025, and down 2.74% on a QoQ basis from $47.4 million in Q3 2025.
ADC Therapeutics (ADCT) Operating Expenses (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Operating Expenses for 7 consecutive years, with $46.1 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | 46.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.10 Mn |
| Sep 30, 2025 | 47.40 Mn |
| Jun 30, 2025 | 62.99 Mn |
| Mar 31, 2025 | 51.50 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 46.45 Mn |
| Mar 31, 2024 | 51.67 Mn |
| Sep 30, 2023 | 50.64 Mn |
| Jun 30, 2023 | 58.93 Mn |
| Mar 31, 2023 | 70.56 Mn |
| Sep 30, 2022 | 79.44 Mn |
| Jun 30, 2022 | 86.70 Mn |
| Mar 31, 2022 | 86.86 Mn |
| Sep 30, 2021 | 70.94 Mn |
| Jun 30, 2021 | 74.24 Mn |
| Mar 31, 2021 | 70.67 Mn |
| Sep 30, 2020 | 52.43 Mn |
| Jun 30, 2020 | 44.95 Mn |
| Mar 31, 2020 | 43.89 Mn |